Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1080/23723556.2017.1308851 http://scihub22266oqcxt.onion/10.1080/23723556.2017.1308851 C5462514!5462514!28616585     free     free     free Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 213.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Mol+Cell+Oncol 2017 ; 4 (3): ä Nephropedia Template TP {{tp|p=28616585|t=2017. Co-targeting cancer stem-like cells and bulk cancer cells with a bispecific antibody |pdf=|usr=}}{{28616585}} gab.com Text Co-targeting cancer stem-like cells and bulk cancer cells with a bispecific antibody JO: Mol Cell Oncol http://www.kidney.de/pget.php?&tw=1&pmid=28616585 #FOAvip Epidermal growth factor receptor (EGFR) is a widely recognized target for tumors, but resistance is commonly reported. Recently, we reported that dual targeting of EGFR and NOTCH2/3 receptors with antibody CT16 showed a strong anti-stem effect both in vitro and in vivo to overcome resistance of EGFR inhibitors and radiation. Twit Text FOAVip Co-targeting cancer stem-like cells and bulk cancer cells with a bispecific antibody ????Mol Cell Oncol http://www.kidney.de/pget.php?&tw=1&pmid=28616585 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=28616585 #FOAvip English Wikipedia <ref>{{Cite pmid|28616585}}</ref> Co-targeting cancer stem-like cells and bulk cancer cells with a bispecific antibody #MMPMID28616585 Hu S Mol Cell Oncol 2017[]; 4 (3): ä PMID28616585show ga Epidermal growth factor receptor (EGFR) is a widely recognized target for tumors, but resistance is commonly reported. Recently, we reported that dual targeting of EGFR and NOTCH2/3 receptors with antibody CT16 showed a strong anti-stem effect both in vitro and in vivo to overcome resistance of EGFR inhibitors and radiation. äCo-targeting cancer stem-like cells and bulk cancer cells with a bispe(epmc).pdf DeepDyve Pubget Overpricing